Metabolic phenotype and risk of colorectal cancer in normal-weight postmenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 2, 2017, Pages 155-161

  Liang, Xiaoyun ^a   Margolis, Karen L ^b   Hendryx, Michael ^c   Rohan, Thomas E ^d   Groessl, Erik J ^e,f   Thomson, Cynthia A ^g   Kroenke, Candyce H ^h   Simon, Michael S ⁱ   Lane, Dorothy ^j   Stefanick, Marcia ^k   Luo, Juhua ^c  

^a BEIJING NORMAL UNIVERSITY   (China)

^b HEALTHPARTNERS INSTITUTE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^g UNIVERSITY OF ARIZONA   (United States)

^h DIVISION OF RESEARCH   (United States)

ⁱ WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j STONY BROOK UNIVERSITY   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CANCER EPIDEMIOLOGY; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HORMONAL THERAPY; HUMAN; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MINERAL SUPPLEMENTATION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHENOTYPE; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SENSITIVITY ANALYSIS; SMOKE; UNITED STATES; VITAMIN SUPPLEMENTATION; BLOOD; BODY MASS; CLINICAL TRIAL; COLORECTAL TUMOR; COMPLICATION; FOLLOW UP; INCIDENCE; MIDDLE AGED; OBESITY; RISK FACTOR;

AGED; BODY MASS INDEX; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; METABOLIC SYNDROME; MIDDLE AGED; OBESITY; PHENOTYPE; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 85013647994     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0761     Document Type: Article

References (28)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
2. American Cancer Society. Cancer facts & figures 2016. Atlanta, GA: American Cancer Society; 2016. Available from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf
3. Esposito K, Chiodini P, Capuano A, Bellastella G,Maiorino MI, Rafaniello C, et al. Colorectal cancer association with metabolic syndrome and its components: A systematic review with meta-analysis. Endocrine 2013;44:634-47.
4. World Cancer Research Fund/American Institute for Cancer Research. Continuous update project report. Food, nutrition, physical activity, and the prevention of colorectal cancer. Washington, DC: American Institute for Cancer Research; 2011.
5. Aran V, Victorino AP, Thuler LC, Ferreira CG. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer 2016;15:195-203.
6. Strum WB. Colorectal adenomas. N Engl J Med 2016;374:1065-75.
7. Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007;32:4-12.
8. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment ofHigh Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
9. Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 2013;36:2294-300.
10. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010;21:38-43.
11. Kramer C, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 2013;159:758-69.
12. Wang B, Zhuang R, Luo X, Yin L, Pang C, Feng T, et al. Prevalence of metabolically healthy obese andmetabolically obese but normal weight in adults worldwide: A meta-analysis. Horm Metab Res 2015;47:839-45.
13. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-24.
14. Alfa-Wali M, Sharma A, Boniface S, Tekkis P, Hackshaw A, Antoniou A. Metabolic syndrome (MetS) and risk of colorectal cancer (CRC): A systematic review and meta-analysis. Ann Oncol 2012;23:22-3.
15. Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GY, et al. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 2009;125:2704-10.
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis andmanagement of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
18. Gunter MJ, Xie X, Xue X, Kabat GC, Rohan TE, Wassertheil-Smoller S, et al. Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Res 2015;75:270-4.
19. Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, et al. Insulin sensitivity indices: A proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes 2006;114:249-56.
20. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003;13:S122-8.
21. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, et al. Implementation of the women's health initiative study design. Ann Epidemiol 2003;13:S5-S17.
22. Murphy N, Cross AJ, Abubakar M, Jenab M, Aleksandrova K, Boutron-Ruault MC, et al. A nested case-control study of metabolically defined body size phenotypes and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS Med 2016;13: e1001988.
23. Kabat GC, Kim MY, Peters U, Stefanick M, Hou L, Wactawski-Wende J, et al. A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women. Eur J Cancer Prev 2012;21:326-32.
24. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28-36.
25. Sturmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev 2006;15:2391-7.
26. De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L. Normal-weight obese syndrome: early inflammation? Am J Clin Nutr 2007;85:40-5.
27. Hyun YJ, Koh SJ, Chae JS, Kim JY, Kim OY, Lim HH, et al. Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normalweight woman. Obesity 2008;16:784-9.
28. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normalweight young women. Diabetes 1999;48:2210-4.